| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vistagen Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,100 | 06 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | 06 Sep 2024 | 1 | $0 | 4 | Director | 10 Sep 2024, 17:00 |
| VTGN | Vistagen Therapeutics, Inc. | 04 Mar 2024 | 1 | $0 | 4 | Director | 06 Mar 2024, 18:00 |
| VTGN | VistaGen Therapeutics, Inc. | 18 Aug 2022 | 2 | +$35,740 | 4 | Director | 22 Aug 2022, 17:12 |
| VTGN | VistaGen Therapeutics, Inc. | 01 Mar 2022 | 1 | $0 | 4 | Director | 03 Mar 2022, 15:13 |